Philips, NL0000009538

Jefferies keeps a EUR 25.00 target for Philips stock

Published on 10/04/2026 at 18:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Jefferies kept its Hold rating and EUR 25.00 target for Philips stock. Weekend trading shows EUR 21.29 versus EUR 21.29 at the last Xetra close.

Fotorealistische Fertigungshalle für Medizintechnik mit Ingenieuren an Scanner-Geräten
Koninklijke Philips N.V. (NL0000009538) zeigt moderne Medizintechnik-Fertigung mit Ingenieuren an High-Tech-Scanner-Anlagen in heller Halle, Illustration mit AI erstellt.

On September 29, 2026, a dpa-AFX report said Jefferies had kept its Hold rating and EUR 25.00 price target for Philips. The report attributed the assessment to analyst Julien Dormois and said he expected 3.00 percent operating revenue growth for the third quarter. FinanzNachrichten reported that the original study was published on September 28, 2026.

Weekend trading at Lang & Schwarz

At 6:21 p.m. CEST on October 4, 2026, Philips was at EUR 21.29 in weekend trading at Lang & Schwarz. The price was unchanged, representing a 0.00 percent change versus the EUR 21.29 close of the last Xetra trading day at Lang & Schwarz on October 2, 2026. The bid was EUR 21.26 and the ask was EUR 21.31. The further course of weekend trading at Lang & Schwarz until 7:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Philips stock.

Philips-led projects receive awards

Royal Philips said on September 16, 2026, that two Philips-led public-private research collaborations had received 2026 ITEA Awards of Excellence. SYMPHONY received the award for “Exceptional Excellence” for connecting healthcare data, clinical workflows and artificial-intelligence-supported decision tools through open, interoperable ecosystems. The project covered four clinical areas: prostate cancer, aortic aneurysm, atrial fibrillation and multiple sclerosis. GlobeNewswire carried the issuer-authored announcement.

The same release said AI FORSchung was recognized for developing artificial-intelligence methods for fiber-optic sensing. Researchers demonstrated that Fiber Optic RealShape position data could be compressed more than 20 times while maintaining performance within the evaluated datasets. Royal Philips also said technology developed within SYMPHONY for automatically segmenting and measuring vascular structures in medical images had received FDA clearance and CE marking.

Next Xetra session

The next Xetra session is scheduled for October 5, 2026.

Disclaimer...

en | NL0000009538 | PHILIPS | boerse | 70227006 | bgmi